Back to resultsGeneral Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment
Primary Purpose
Pulmonary Disease, Chronic Obstructive
Status
Completed
Phase
Locations
Study Type
Observational
Intervention
Education
Sponsored by
About this trial
This is an observational trial for Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Inclusion Criteria: COPD patients over 35 years of age More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these Exclusion Criteria: Asthma
Sites / Locations
Outcomes
Primary Outcome Measures
To optimise the diagnosis and treatment of COPD via a quality assurance project
Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
To focus on implementation of national guidelines for diagnosis and treatment of COPD
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00319813
Brief Title
General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment
Official Title
General Practice Quality Assurance Project. COPD Diagnosis and Treatment
Study Type
Observational
2. Study Status
Record Verification Date
April 2008
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2007 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Boehringer Ingelheim
4. Oversight
5. Study Description
Brief Summary
A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
7. Study Design
Enrollment
8000 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Education
Primary Outcome Measure Information:
Title
To optimise the diagnosis and treatment of COPD via a quality assurance project
Title
Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
Title
To focus on implementation of national guidelines for diagnosis and treatment of COPD
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
COPD patients over 35 years of age
More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these
Exclusion Criteria:
Asthma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim Study Coordinator
Organizational Affiliation
B.I. Denmark A/S
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment
We'll reach out to this number within 24 hrs